Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00125788
Status:
COMPLETED
Last Update Posted:
2021-01-29
First Post:
2005-08-01
Brief Title:
L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
Sponsor:
Emmaus Medical Inc
Organization:
Emmaus Medical Inc
Organization Data
Organization:
Emmaus Medical Inc
Class:
INDUSTRY
Study ID:
10478
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Emmaus Medical Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| FDA Office of Orphan Products Development | FED |